Date: 22.5.2013
Waterproof fabrics that whisk away sweat could be the latest application of microfluidic technology developed by bioengineers at the University of California, Davis.
The new fabric works like human skin, forming excess sweat into droplets that drain away by themselves, said inventor Tingrui Pan, professor of biomedical engineering. One area of research in Pan's Micro-Nano Innovations Laboratory at UC Davis is a field known as microfluidics, which focuses on making "lab on a chip" devices that use tiny channels to manipulate fluids. Pan and his colleagues are developing such systems for applications like medical diagnostic tests.
Graduate students Siyuan Xing and Jia Jiang developed a new textile microfluidic platform using hydrophilic (water-attracting) threads stitched into a highly water-repellent fabric. They were able to create patterns of threads that suck droplets of water from one side of the fabric, propel them along the threads and expel them from the other side.
It's not just that the threads conduct water through capillary action. The water-repellent properties of the surrounding fabric also help drive water down the channels. Unlike conventional fabrics, the water-pumping effect keeps working even when the water-conducting fibers are completely saturated, because of the sustaining pressure gradient generated by the surface tension of droplets.
The rest of the fabric stays completely dry and breathable. By adjusting the pattern of water-conducting fibers and how they are stitched on each side of the fabric, the researchers can control where sweat is collected and where it drains away on the outside.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Brigady pro studenty - Brigady pro studenty
Biotechnology legislative - Biotech legislative environment search
Silicon exoskeletons for blood cells: Engineered blood cells successfully transfused between species
CRISPR-Cas10 can flood virally infected bacteria with toxic molecules, researchers discover